OptiBio is a South Korean in-vitro diagnostics (IVD) company focused in researching, developing, and manufacturing cutting edge fluorescence immunoassay (FIA) solutions. In 2020, OptiBio was selected by a research fund sponsored by the Bill & Melinda Gates foundation for its unique and dedicated approach to immunoassay.
Our fundamental approach to in-house development allows OptiBio to constantly improve product performance, customize solutions based on client feedback, develop new test parameters, and respond to changing market needs. Shortly following the outbreak of Covid-19, for example, OptiBio quicky developed the Optical Q SARS-CoV-2 neutralizing antibody (nAb) test kit.
OptiBio will continue to create, improve, and innovate world class diagnostic solutions in the field of fluorescence immunoassay and point-of-care testing (POCT). Through this, we aim to ultimately transform medical diagnosis into a universally available right.
Company Details
- Employees
- 6
- Founded
- -
- Address
- Cheongju, Kr
- Industry
- Medical Equipment Manufacturing
- NAICS
-
Medical Equipment and Supplies ManufacturingSurgical and Medical Instrument ManufacturingSurgical Appliance and Supplies ManufacturingDental Equipment and Supplies ManufacturingOphthalmic Goods ManufacturingDental Laboratories
- Website
- http://www.optibio.co.kr
- Keywords
- diagnostics, immunoassay, point of care, medical device, in vitro diagnostics, fluorescence immunoassay, POCT, FIA, IVD.
- HQ
- Cheongju
Optibio Questions
Optibio's website is http://www.optibio.co.kr
Optibio's LinkedIn profile is https://kr.linkedin.com/company/optibio
Optibio has
6 employees.
View email and phone details for 6
employees at Optibio.
Optibio's industry is
Medical Equipment Manufacturing
Optibio's top competitors are
Sibionics,
Syai Health,
Jat Medical,
Ultra Diagnostic,
Optibio Supplements,
Debakey Diagnostic,
Plabio S.r.o.,
Infinovo,
Kenaaz Medical,
Plabio.
Optibio's categories are Medical Equipment Manufacturing
Optibio's founding year is 2019
